CAPOZIDE 25/25 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Capozide 25/25, and when can generic versions of Capozide 25/25 launch?
Capozide 25/25 is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in CAPOZIDE 25/25 is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Capozide 25/25
A generic version of CAPOZIDE 25/25 was approved as captopril; hydrochlorothiazide by RISING on December 29th, 1997.
Summary for CAPOZIDE 25/25
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 13 |
Clinical Trials: | 1 |
Patent Applications: | 9 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CAPOZIDE 25/25 at DailyMed |
Recent Clinical Trials for CAPOZIDE 25/25
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for CAPOZIDE 25/25
US Patents and Regulatory Information for CAPOZIDE 25/25
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | CAPOZIDE 25/25 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-002 | Oct 12, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CAPOZIDE 25/25
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apothecon | CAPOZIDE 25/25 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-002 | Oct 12, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Apothecon | CAPOZIDE 25/25 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-002 | Oct 12, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CAPOZIDE 25/25
See the table below for patents covering CAPOZIDE 25/25 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S58189158 | PROLINE DERIVATIVE AND RELATED COMPOUNDS | ⤷ Try a Trial |
Hungary | 185576 | PROCESS FOR PRODUCING N-ACYLIZED L-PROLINE DERIVATIVES | ⤷ Try a Trial |
Argentina | 226290 | PROCEDIMIENTO PARA PREPARAR NUETOALQUIL-(C1-C3)-CARBONIL)-L-PROVOS DERIVADOS DE ACIDO-1-(MERCAPLINA,Y SUS SALES | ⤷ Try a Trial |
Australia | 507660 | ⤷ Try a Trial | |
Australia | 526239 | ⤷ Try a Trial | |
U.S.S.R. | 860697 | METHOD OF PREPARING DERIVATIVES OF DEHYDROCYCLIC IMINOACIDS | ⤷ Try a Trial |
France | 2340932 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |